Hashim M Aljohani

7PUBLICATIONS
33CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyMolecular targetsNoise and wave pollution processes and measurement
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 27, 2025
Exploring Novel Inhibitory Compounds Against Phosphatase Gamma 2: A Therapeutic Target for Male Contraceptives.

Hashim M Aljohani, Bayan T Bokhari, Alaa M Saleh

|Jul 30, 2025
Is Anlotinib and Radiotherapy Combination Effective for Non-Small-Cell Lung Cancer with Brain Metastases? A Systematic Scoping Review and Meta-Analysis.

Helal F Hetta, Mostafa A Sayed Ali, Saleh F Alqifari

|Apr 26, 2025
Synergizing Success: The Role of Anlotinib Combinations in Advanced Non-Small Cell Lung Cancer Treatment.

Helal F Hetta, Hashim M Aljohani, Nizar Sirag

|Mar 27, 2025
Beyond Conventional Antifungals: Combating Resistance Through Novel Therapeutic Pathways.

Helal F Hetta, Tameem Melhem, Hashim M Aljohani

|Mar 26, 2025
Immunomodulatory Effect of Rivaroxaban Nanoparticles Alone and in Combination with Sitagliptin on Diabetic Rat Model.

Mohamed M Elbadr, Heba A Galal, Helal F Hetta

Pageof 2